In fact I started to' apply cold to humans with my Chief and friend Doctor Olivier Monod only recently. As the phenomena observed above 25-20°C. are strikingly different from those observed below the 200 C. range, I would suggest the following definitions in this new field of cold therapy (see Juvenelle et al., 1952; Juvenelle, 1952): Hypothermia: Cooling of the whole body down to a temperature of 250 C. regardless of the means used to, attain this cooling.
Deep Hypothermia: Cooling of the whole body from 25°C. downwards. Hibernation: A normal biological winter sleep in certain species. Artificial hibernation: The induction of hibernation in the hibernating animal at a time when it would not spontaneously go into hibernation (N.B.-There should be no such thing as artificial hibernation during summer, since hibernation, etymologically speaking, means winter sleep).
Refrigeration: The cooling of a part of the body. In its modern aspect of therapy the pioneering has been done by men like Allen, Smith, Fay, Talbott and Templeton almost fifteen years ago. More recently, Bigelow applied the biological properties of cold to cardiac surgical problems. Laborit developed a method of anesthesia for which great advantages are claimed; this method he and his co-workers named "artificial hibernation," after Simpson. Today almost anything that puts a patient to sleep is called artificial hibernation, so that little by little another irrational, emotional and almost pre-logical concept is being introduced in Medicine. I do not believe that the so-called ganglioplegic drugs are of use in the low temperature range; indeed I believe they are dangerous then. These drugs cannot, in themselves, reduce metabolism to a much lower degree than other drugs like ether. Cold, as we need it in various types of surgery, should be resorted to to reduce metabolism to a very low level and drugs are to be considered with extreme caution in this respect. We want to be able to work into the heart cavities, we want to be able to close the aorta above the renal arteries for a prolonged period, we want to offer the critically ill patient a satisfactory relief when oxygen is badly needed, we want to utilize a reduced artificial heart-lung system; we look to cold to meet these requirements.
It may be possible that some day we, will be given another wonder drug, a drug which would arrest life for a predetermined length of time, or at will would decrease its metabolic rate. But it is my belief that until this Rip Van Winkle-making agent is discovered, cold is the best agent we know capable of reducing tissue metabolism at will.
(a) In order to induce cooling in a non-hibernating animal it is necessary to prevent shivering and to annihilate consciousness. Any anesthetic that can prevent shivering can be used. However, the ideal non-toxic agent has not yet appeared.
(b) Consciousness may be obliterated by anesthesia. Shivering may also be prevented in a number of ways, even by means of Largactil, Phenergan and curare, but I prefer to use the simplest way: ether.
(c) In other words there is not the smallest difficulty due to the induction of cooling. However, the effects of shivering-blocking agents may be entirely different at low body temperatures, and one of the major problems in this field of hypothermia is the utilization of the least toxic, rapidlyeliminated agent or combination of agents.
Barbiturates are poorly eliminated by the cold animal, and the colder the temperature the slower the elimination, there even seems to be a summation of repeated injections of the drug during cooling.
In the 200 C. range no further anesthesia seems necessary. Respiration stops around 26-30' C. under Nembutal anesthesia, it stops around 17-150 C. under ether. The better results observed under ether as far as ventricular fibrillation is concerned are probably related to a better ventilation under ether with better CO2 elimination and consequently more adequate blood pH.
Considerable biochemical changes are observed in the blood during hypothermia. It is obvious that these changes may be of very little significance since we do not know what happens in the cells themselves. I daresay, however, they are not very deleterious biologically in view of the fact that they are reversible.
It is known that if pre-cooling anesthesia is satisfactory, the oxygen consumption is reduced parallel to the drop in rectal temperature. And since it has been possible in many of my own dogs to get them back to normal behaviour after reduction in body temperature as low as 120 C., there are some reasons to believe that the 02 uptake is, within limits, a valuable indicator of tissue metabolism. I cannot ascertain, however, whether an oxygen debt has not been accumulated during the cooling period to be paid back during the rewarming period. Should this be the case, important organs are certainly capable of removing 02 without any debt: the brain tissue cannot accumulate such a debt, nor can the medulla, and the heart is not able to stand it any longer.
Therefore, I am driven to the conclusion that cold, in itself, does not prevent the tissues getting oxygen from the blood. It is important in this respect to remember that the heart has been shown capable of removing oxygen in a normal way at 170 C. with a partial pressure of 02 of no more than 17 mm.Hg. On the other hand it is known that cold produces a leftward shift of the Ib dissociation curve; accordingly it has been claimed that the tissues could not remove enough for their need. This has been disproved although not entirely. When ventricular fibrillation appears, we have been able to maintain this condition during a mean period of two and a half hours by means of an artificial circulation, and get 6 animals out of 14 alive after rewarming from temperatures ranging from 12 to 200 C. (cf. "A new method of extra-corporeal circulation", Juvenelle, Lind and Wegelius, 1954).
The minute blood flows used to support the entire animal were ten to twenty times lower than they should have been at normal temperature. ECGs taken during these experiments may be consulted in the paper referred to.
It has also been shown that under ventricular fibrillation the heart oxygen uptake is equivalent to what it is during normal work. Ventricular fibrillation is an expenditure of energy, and it remains to be seen if this expenditure can compare to the normal work during normal beating at any temperature. I believe, with no definite proof, that it can, provided the coronary circulation is supplied with fully oxygenated blood during fibrillation. Should this prove true, the experiment just referred to would prove that the ability to secure a good oxygen supply to the cold tissue is not curtailed by an intrinsic inability of these tissues to remove oxygen.
In any case, in a large number of dogs cooled to a mean temperature of 160 C., all fibrillating under an artificial circulation, during more than a mean period of two and a half hours we have always been able' to get the heart back to normal beating. We had three failures, and all three were satisfactorily explained. This is so clear to me that I will venture to repeat that: When the heart starts to fibrillate (ventricular fibrillation), it is ALWAYS feasible to return it to normal beating, provided the coronary circulation has been properly maintained during fibrillation, with adequate oxygen supply to the arterial blood. It may be worth noting in this respect that in one case the artificial circulation supporting the entire animal (which was not breathing) lasted for seven hours and the ventricular fibrillation for five hours. The temperature was 120 C. for many hours. The dog did very well after rewarming. After a few days the ECG and the EEG were identical to pre-hypothermia controls on the same dog.
Blood pressure maintains a good level down to about 250 C., then it starts to get lower. Incidentally I have found, quite empirically, that the B.P. of dogs given antihistaminics prior to hypothermia keeps at a much higher level than in dogs not so prepared. Since an adequate B.P. seems to offer advantages in the low temperature range, I give my dogs antihistaminics. I have no explanations to offer for this action of antihistaminics. Below 250 C. the B.P. starts to decrease and may reach very low levels. If anesthesia is adequate and prevents shivering the pulse will start its fall parallel to the temperature fall.
From the biochemical angle we (Juvenelle et al., 1953) have found many changes. These changes are remarkably comparable to the changes that are observed in the hibernating animal. Moreover they are reversible to normal on rewarming.
Many people will ask: Has cold no dangers, is it as safe as you say?
It seems to be so in the hibernating animal -in which the rectal temperature may almost reach freezing point. In the ordinary mammal, ventricular fibrillation occurs at about 1618' C. I consider in fact that it is of fundamental importance for scientific as well as ethical reasons to emphasize differences rather than similarities. From this we shall note that in the hibernating animal all normal neurological automatic systems are maintained efficiently whatever the rectal temperature. More precisely, respiration and heart beat persist adequately for many months at central temperatures as low as 3-50 C. In the non-hibemating mammal the heart fails around 200 C. Respiration stops at the same temperature under ether or nitrous oxide anesthesia, with barbiturates it stops much earlier.
In hibernators, the isolated nerve transmits impulses down to freezing point, in the ordinary mammal the isolated nerve is blocked about 6-80 C.; in my opinion, these are the fundamental differences. Until they are cleared up, we must act with caution in the low temperature range. I think that heart failure in cold is the expression of a combined cardiac conduction and excitation breakdown plus a metabolic interference with normal processes (polarization and depolarization of membranes).
To be able to reach the very low temperature range without any artificial circulation even for brief periods of time we need much more knowledge. SUMMARY In our estimate, cold has no seriously deleterious after-effects, when the temperature has not gone lower than 25-200 C. (this 50 difference expresses presumable differences in techniques of cooling including anesthesia), the same holds true for man as for dogs. Our ultimate objective could be to imitate the hibernating animal both as far as the degree and the length of cooling are concerned, but at present we cannot compare an animal which can stand a few hours or a few days at 250 C. or, as in Laborit's method, at 32-35°C., to another which normally stays for months every year at 3 to 5o. This is one reason why I reject the term Artificial Hibernation. It is absurd to compare a man "artificially hibernated", because he is suffering from let us say peritonitis, to another animal which is hibernating naturally (and has been doing so for thousands of centuries) and which is in perfect health.
What is the present position ofhypothermia? In order to give the patient a fair chance, I started by postulating that until we know more, we must consider hypothermia as an insult of an unknown degree and possibly an important one in the severely ill patient.
Indications are then easier to discuss, at. least at the outset of a new method: It is by balancing the surgical risk against the risk with the adjunction of hypothermia that we may hope to select the proper candidates for this type of treatment without undue accidents.
Only the experience of many will permit us to get a better appreciation of the risks involved and perfection of the method. There is a need for close co-operation between many workers in this field.
To-day as we are still at an experimental stage I can only describe the policy that Doctor Olivier Monod and myself have tentatively adopted. Cold seems to us to be of use whenever it is imperative to lower metabolism considerably without undue danger and with possible and rapid reversal to normal, and with good control over the biological variables as well.
It also appears to be valuable whenever the surgical riskper se would seem to be far too great without it. (Surgical-shock has almost disappeared from the large centres in the J.S.A. and in many places in Europe, but it is still a drawback in many other places.) From these requirements it can be seen that we consider the use of the so-called "ganglioplegic" drugs-as useless in conjunction with hypothermia and possibly dangerous, at least in the way they are now handled. We also believe that:
(a) Cold (centrally) should be of a sufficient level to meet the requirements (23-260 C.). (b) Pre-hypothermia anesthesia should be accomplished with the least possible drugs. Ether is satisfactory until we get a better agent.
(c) Patients with low cardiac reserve should be cooled with great caution. (d) -Patients with low respiratory reserves should be cooled with even greater caution and adequate means of artificial respiration with a closed chest (blow and suck system).
Suitable subjects are at the present time: (a) Infants with congenital cardiac defects in which operation carries a very high mortality (over 25 %) due to anoxia during or after operation. In these babies we now maintain a temperature of around 300 C. during pre-operative days (until 2-3 months, blue babies do not need drugs for this; they do not shiver and their temperature drops by simply removing part of their clothes). We operate upon these infants in the 200 C. range.
(b) Adults with respiratory insufficiency, upon whom a thoracic operation (pulmonary) is desirable but prohibited because of fear of oxygen lack. Doctor Monod and myself have operated on several of these cases at a temperature of 23-260 C. Our general impression is favourable, but we cannot yet seriously assess the value of the method on such a small group of cases.
(c) Adults or very old people in whom operation carries a very high mortality rate, with the hope of reducing the surgical insult. (d) Artificial circulation with heart/lung system: This I believe will be one of the major indications of hypothermia. We recommended the use of this combined procedure in 1951, and since that time we have shown that it was feasible. The main advantages we have described elsewhere.
It is imperative to have a precise definition to our meaning if we are to gain experience from each other. The phenomenona encountered in hypothermia are so strikingly different according to thermal levels and/or to pre-hypothermia anesthesia that we cannot be satisfied to read in an account that "an artificial hibernation" has been induced. We certainly need more precision than that, both in thinking and in ways of expression. I suggest in closing that an international agreement be reached on definitions in this field. dropped in temperature to 840 F. (290 C.) without any artificial cooling other than exposure to room temperature. In addition to a number of cases in which we used Largactil we have, however, had at Westminster three successful hypothermic anesthesias in children for the performance of Blalock's operation for Fallot's tetralogy. In these no special drugs were used.
The set-up is shown in Fig. 1 and the various items are as seen. The child is anesthetized and intubated in the usual way and then placed on the cooling blanket and the blanket is then closed and the circulation of freezing mixture is begun. The temperature falls as shown in this chart (Fig. 2) At 80°F. (27°C.) the aniesthetic is discontinued and 100% 02 used for the inflation. Shortly afterwards operation is begun.
The following points seem worthy of brief note, but I hope I may be forgiven for putting these conclusions on such a small number of cases.
(I) The pulse-rate falls in this instance to between 30 and 49. Continuous ECG control was used and no worrying cardiac abnormalities were seen, despite the bradycardia-which I feel to be far less worrying than the tachycardia so common in these cases when conventional an~esthetic methods are used. I think that the well-known effect of too low a temperature leading to ventricular fibrillation does not necessarily connote increased cardiac irritability. Mechanical stimuli have not produced any cardiac irregularities.
(2) Despite cessation of the cooling circulator and even substitution of warm fluid, the child's temperature continues to fall for half an hour or so. If this is not borne in mind the desired level may be overshot. CC
(3) These blue babies become pink when well cooled. It is a great comfort to be able to inflate them with 100% oxygen. One has to balance the reduced metabolic demand for 03 against the reduced oxyhimoglobin dissociation at low temperature-we feel that this balance is favourable to the method.
(4) Reduced bleeding in the operative field is not a feature of this method, indeed the blood clotting time is trebled at this temperature-this has not seemed to lead to increased bleeding and may reduce the tendency to thrombosis in these cases.
(5) The simplicity and rapidity of producing hypothermia by external cooling in this manner is very pleasing End one feels, therefore, that in children it is preferable to extra-corporeal circulation and cooling. We have been very-happy with the anesthetic, operative, and post-operative course of these cases and feel that, this is probably the anesthetic method of choice for them. Dr. G. Vourc'h (of Paris): The term Artificial Hibernation, such as is used by some French writers, -is most confusing and, in my opinion, ought to be abandoned as cold plays little part in the technique. The whole concept is very vague; it seems to me they are trying to force the facts to fit their theory. Their claims of wonderful results do not stand careful investigation: they assume that most of the cases were lost anyhow; therefore, should they die, it would be in spite of the technique; should they survive, it is because of it. One hears a lot about the successes, and hardly at all about the failures, which are, nevertheless, real. Their figures do not substantiate their claims: 30% mortality is very high, artificial hibernation or not.
What, in all this, is the place of Largactil, or chlorpromazine, is hard to tell. Some of the claims made for it are wrong; for instance, it has been presented as ganglionic blocking, which it is not. It would be a pity if an interesting drug should fall in discredit because of these fantastic claims; it is certainly worth careful, scientifically conducted clinical investigations. One thing is certain: it is a strong central depressant, and nearly all its actions can be attributed to this; it has its place among many other drugs to achieve one purpose, i.e. sedation. Apart from that, there is no evidence that it can work miracles by itself through some obscure "lytic" or " disconnecting" action. Because it is such a strong depressant, it may hide the patient's true condition; treating the symptom is not always curing the disease. What criteria, for instance, persuade a ward sister to say that" a patient does well under Largactil"? It may be, of course, that he is in fact very well; but it may be also that she finds he is well only because he is in a state of semi-stupor, with a low temperature and no cough, because the regulating mechanisms and reflexes are depressed. As Dr. Beard has pointed out, it is sometimes surprising to find that suction brings up quite a lot of unsuspected sputum. Some good anesthetists in France are still trying the drug and assessing what its real position in anesthesia should be. To some it seems that its indications are medical rather than surgical: severe hyperthermia, encephalitis, cerebral hemorrhage, mental cases, etc. Refrigeration of the whole body offers probably more scope in cardiac surgery than Largactil does; it can be achieved without it, and Dr. Juvenelle seems to think that the toxicity of the drug is too big at low temperatures to be used safely for that purpose.
Dr. D. A. B. Hopkin: Dr. Bernard Kenton drew my attention to the possibilities of the phenothiazine derivatives in anesthesia three months ago, and since then he and I have administered them either singly or in combination to over two hundred patients; many poor risks, mostly elderly, and a few in hemorrhagic shock.
For patients undergoing operations of moderate severity, premedication with promethazine/pethidinef atropine replaces the well-known Omnopon/scopolamine. Pre-operative sedation is excellent. Patients are calmer, and more drowsy than with the older methods. Anwsthesia is smooth and easy, and is remarkably free from respiratory disturbance and depression. The dose of Pentothal is reduced by 20%, and the effect of nitrous oxide seems to be enhanced.
The post-operative condition of these patients is a subject of favourable comment by experienced ward sisters. Restlessness and vomiting are rare, and nursing is much easier. On the day following operation patients appear fresher and more alert. These are admittedly only impressions, but being backed by unanimously favourable nursing opinion in different hospitals we consider they are significant.
For poor risks, and all major operations, we have used a combination of promethazine, chlorpromazine, pethidine, and atropine. We have made no attempt to induce hypothermia. We have been impressed by the ability of patients under the influence of these drugs to withstand severe trauma without showing the signs of shock that one would normally expect. We have also found that our calls on the blood transfusion services have been reduced, during and after operation. Post-operative condition is excellent and many patients require no sedation in the immediate post-operative period.
Since we have been using chlorpromazine we are more prepared to accept risks which formerly we would have refused. Our reason for doing this is based on the feeling of security from the development of operative shock of a severity likely to prove fatal, especially in elderly patients who have to undergo radical operations for extensive malignant disease.
Our knowledge of the pharmacology of these drugs, especially chlorpromazine, is still incomplete. The central action of the latter is extremely interesting, and in the absence of exact information is likely to give rise to considerable speculation. There is no doubt, however, that its elucidation may enable us to obtain a clearer picture of the pathogenesis of the various manifestations of shock.
We may have to revise particularly our present views about the changes which occur in the peripheral circulation, and the factors which influence vasomotor tone.
Apart from these theoretical considerations we consider that from a practical point of view these drugs are of real benefit to both patient and anesthetist, and are an important advance in anesthetic technique.
Dr. David Morris: In a recent visit to Paris it was my good fortune to see artificial hibernation used in clinical medicine (Morris, 1953 , Lancet, ii, 1039 . In premature infants, ill from birth injury or hyaline membrane of the lung Largactil was given by mouth in hourly divided doses of 1-2 mg. per kilo per day continued for four to five days; the dose was regulated for the effects of "disconnection" rather than hypothermia. It was also being used on children very ill with infections not responding to the standard methods of treatment; in these a mixture of Largactil, pethidine and pbenobarbitone was given intravenously. The use of Largactil in the treatment of congenital pyloric stenosis illustrates its valuable anti-vomiting properties. This new method of treatment, applicable in a variety of clinical conditions is surely worthy of further trial whereby we will learn in more detail its evaluation. Dr. 0. P. Duinnck: I have been using Phenergan as an additional drug for premedication for about three years, and would like to support previous speakers in affirming its usefulness. I have found it valuable for three reasons.
Firstly, in the anesthetic management of asthmatics and chronic bronchitis patients with bronchospasm and a hyperactive cough reflex. Although Phenergan has not proved to be of great value in the clinical management of these cases, there is no doubt that premedication with this drug makes them much more controllable under anesthesia. Not only, as noted by other speakers, are the laryngeal reflexes less active, but even more noticeable, there is much less tendency for bronchospasm to occur in response to anesthetic or surgical stimuli. For example, after Phenergan in this type of case, nitrous oxide, oxygen and ether inductions-even by inexperienced students-have been remarkably smooth, when normally much difficulty would be expected.
Secondly, when extra pre-operative sedation is required, especially in those patients who are accustomed to taking large doses of barbiturates, or when it is desired to avoid the uncertain cumulative effect of mixed barbiturate medication.
Thirdly, for its anti-emetic value. Dr. Beard has mentioned the many difficulties involved in evaluating this attribute of a drug and I will not elaborate them. However, my impression is that this property of Phenergan is a very real one. My most convincing evidence comes from a group of patients who have had multiple operations of similar magnitude, some of whom now demand the drug pre-operatively. I have given a dose of 50 mg. for the average adult patient, administered by mouth about thre to six hours before operation. I have seen no alarming falls of blood pressure or other untoward effects which could be attributable to the drug, and in only one case was post-operative stupor sufficiently deep and prolonged as to give rise to comment. This case caused no anxiety, however, and had also received relatively large doses of other depressant drugs.
